Huihui Mou

5.2k total citations · 2 hit papers
19 papers, 2.9k citations indexed

About

Huihui Mou is a scholar working on Infectious Diseases, Animal Science and Zoology and Molecular Biology. According to data from OpenAlex, Huihui Mou has authored 19 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 7 papers in Animal Science and Zoology and 4 papers in Molecular Biology. Recurrent topics in Huihui Mou's work include SARS-CoV-2 and COVID-19 Research (13 papers), COVID-19 Clinical Research Studies (8 papers) and Animal Virus Infections Studies (7 papers). Huihui Mou is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (13 papers), COVID-19 Clinical Research Studies (8 papers) and Animal Virus Infections Studies (7 papers). Huihui Mou collaborates with scholars based in United States, China and Netherlands. Huihui Mou's co-authors include Bart L. Haagmans, Berend‐Jan Bosch, V. Stalin Raj, Peter J. M. Rottier, Albert D. M. E. Osterhaus, Christian Drosten, Marcel A. Müller, Saskia L. Smits, Jeroen Demmers and Volker Thiel and has published in prestigious journals such as Nature, Nature Communications and Nature Biotechnology.

In The Last Decade

Huihui Mou

19 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

2013 1.5k citations V. Stalin Raj, Huihui Mou et al. Nature profile →
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

2020 662 citations Lizhou Zhang, Cody B. Jackson et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Huihui Mou United States	13	2.4k	709	556	262	240	19	2.9k
Susanne Pfefferle Germany	24	2.4k 1.0×	537 0.8×	492 0.9×	392 1.5×	267 1.1×	63	3.2k
Trevor Scobey United States	17	2.1k 0.9×	789 1.1×	343 0.6×	215 0.8×	260 1.1×	28	2.4k
Craig Fett United States	15	2.2k 0.9×	503 0.7×	507 0.9×	301 1.1×	597 2.5×	21	3.0k
Kumari G. Lokugamage United States	23	2.7k 1.1×	759 1.1×	822 1.5×	228 0.9×	524 2.2×	35	3.3k
Miyuki Kawase Japan	16	2.7k 1.1×	525 0.7×	459 0.8×	475 1.8×	372 1.6×	35	3.3k
Sho Iketani United States	18	1.9k 0.8×	286 0.4×	673 1.2×	221 0.8×	236 1.0×	25	2.3k
James Brett Case United States	23	2.2k 0.9×	288 0.4×	736 1.3×	309 1.2×	337 1.4×	35	3.0k
To Sing Fung China	21	1.6k 0.7×	558 0.8×	603 1.1×	309 1.2×	323 1.3×	33	2.3k

Countries citing papers authored by Huihui Mou

Since Specialization

Citations

This map shows the geographic impact of Huihui Mou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huihui Mou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huihui Mou more than expected).

Fields of papers citing papers by Huihui Mou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huihui Mou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huihui Mou. The network helps show where Huihui Mou may publish in the future.

Co-authorship network of co-authors of Huihui Mou

This figure shows the co-authorship network connecting the top 25 collaborators of Huihui Mou. A scholar is included among the top collaborators of Huihui Mou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huihui Mou. Huihui Mou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Bailey, Charles C., Tianling Ou, Xin Liu, et al.. (2024). In vivo affinity maturation of the CD4 domains of an HIV-1-entry inhibitor. Nature Biomedical Engineering. 8(12). 1715–1729. 8 indexed citations

Otsuka, Yuka, Lizhou Zhang, Huihui Mou, et al.. (2024). Simultaneous screening for selective SARS-CoV-2, Lassa, and Machupo virus entry inhibitors. SLAS DISCOVERY. 29(6). 100178–100178. 2 indexed citations

Zhang, Lizhou, Amrita Ojha, Klaus N. Lovendahl, et al.. (2023). Cytoplasmic Tail Truncation Stabilizes S1-S2 Association and Enhances S Protein Incorporation into SARS-CoV-2 Pseudovirions. Journal of Virology. 97(3). e0165022–e0165022. 6 indexed citations

Evans, David T., et al.. (2021). Predicting the efficacy of COVID-19 convalescent plasma donor units with the Lumit Dx anti-receptor binding domain assay. PLoS ONE. 16(7). e0253551–e0253551. 4 indexed citations

Mou, Huihui, Brian D. Quinlan, Haiyong Peng, et al.. (2021). Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2. PLoS Pathogens. 17(4). e1009501–e1009501. 34 indexed citations

Crooks, Emma T., E. Duggan, Jinsong Zhang, et al.. (2021). Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens. PLoS Pathogens. 17(10). e1009807–e1009807. 8 indexed citations

Tran, Mai H., HaJeung Park, Christopher L. Nobles, et al.. (2021). A more efficient CRISPR-Cas12a variant derived from Lachnospiraceae bacterium MA2020. Molecular Therapy — Nucleic Acids. 24. 40–53. 29 indexed citations

Ou, Tianling, Huihui Mou, Lizhou Zhang, et al.. (2021). Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2. PLoS Pathogens. 17(1). e1009212–e1009212. 143 indexed citations

Riou, Catherine, Georgia Schäfer, Elsa Du Bruyn, et al.. (2021). Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2-specific T-cells. European Respiratory Journal. 59(1). 2100285–2100285. 9 indexed citations

10.

Guo, Yan, Wenhui He, Huihui Mou, et al.. (2021). An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines. mBio. 12(3). 19 indexed citations

11.

Zhang, Lizhou, Cody B. Jackson, Huihui Mou, et al.. (2020). SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity. Nature Communications. 11(1). 6013–6013. 662 indexed citations breakdown →

12.

Quinlan, Brian D., Huihui Mou, Lizhou Zhang, et al.. (2020). The SARS-CoV-2 Receptor-Binding Domain Elicits a Potent Neutralizing Response Without Antibody-Dependent Enhancement. SSRN Electronic Journal. 26 indexed citations

13.

Zhong, Guocai, Haimin Wang, Wenhui He, et al.. (2019). A reversible RNA on-switch that controls gene expression of AAV-delivered therapeutics in vivo. Nature Biotechnology. 38(2). 169–175. 75 indexed citations

14.

Mou, Huihui, Guocai Zhong, Matthew R. Gardner, et al.. (2018). Conditional Regulation of Gene Expression by Ligand-Induced Occlusion of a MicroRNA Target Sequence. Molecular Therapy. 26(5). 1277–1286. 23 indexed citations

15.

Raj, V. Stalin, Mart M. Lamers, Saskia L. Smits, et al.. (2015). Identification of Protein Receptors for Coronaviruses by Mass Spectrometry. Methods in molecular biology. 1282. 165–182. 12 indexed citations

16.

Raj, V. Stalin, Huihui Mou, Saskia L. Smits, et al.. (2013). Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 495(7440). 251–254. 1530 indexed citations breakdown →

17.

Mou, Huihui, V. Stalin Raj, Frank J. M. van Kuppeveld, et al.. (2013). The Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies. Journal of Virology. 87(16). 9379–9383. 181 indexed citations

18.

Reusken, Chantal, Huihui Mou, Gert-Jan Godeke, et al.. (2013). Specific serology for emerging human coronaviruses by protein microarray. Eurosurveillance. 18(14). 20441–20441. 74 indexed citations

19.

Ohnuma, Kei, Bart L. Haagmans, Ryo Hatano, et al.. (2013). Inhibition of Middle East Respiratory Syndrome Coronavirus Infection by Anti-CD26 Monoclonal Antibody. Journal of Virology. 87(24). 13892–13899. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susanne Pfefferle Breakdown of academic impact, for papers by Trevor Scobey Breakdown of academic impact, for papers by Craig Fett Breakdown of academic impact, for papers by Kumari G. Lokugamage Breakdown of academic impact, for papers by Miyuki Kawase Breakdown of academic impact, for papers by Sho Iketani Breakdown of academic impact, for papers by James Brett Case Breakdown of academic impact, for papers by To Sing Fung